C12N 2770/36271
Demonstrated in vivo effect
C12N2770/36271 (Demonstrated in vivo effect) appears on 1 US grants and 2 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 2
- Assignees
- 3
- Inventors
- 4
- Latest grant
- 14 Feb 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
By publication year.
Recent patents
- Vaccination against japanese encephalitis, measles, mumps and rubella1 Oct 2015US 2015/0273035 A1Sanofi Pasteur Limited
- Live, attenuated rubella vector to express vaccine antigens19 Mar 2015US 2015/0079123 A1The United States of America, as represented by the Secretary, Dep. of Health and Human Services
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.